TY - JOUR
T1 - Pharmacological modulation, preclinical studies, and new clinical features of myocardial ischemic preconditioning
AU - Napoli, Claudio
AU - Pinto, Aldo
AU - Cirino, Giuseppe
PY - 2000
Y1 - 2000
N2 - The term "ischemic preconditioning (PC)" was first applied to canine myocardium subjected to brief episodes of ischemia and reperfusion that tolerated a more prolonged episode of ischemia better than myocardium not previously exposed to ischemia. Protective effect of myocardial ischemic PC was demonstrated in several animal species, resulting in the strongest endogenous form of protection against myocardial injury, jeopardized myocardium, infarct size, and arrhythmias other than early reperfusion. New onset angina before acute myocardial infarction, episodes of myocardial ischemia during coronary angioplasty or bypass surgery, and the "warm-up" phenomenon may represent clinical counterparts of the PC phenomenon in humans. Here, we have attempted to summarize pharmacological modulation, preclinical studies, and new clinical features of ischemic PC. To date, the pathophysiological basis of the "chemical PC" is still not well established, and "putting PC in a bottle" for clinical applications still remains a new pharmacological venture.
AB - The term "ischemic preconditioning (PC)" was first applied to canine myocardium subjected to brief episodes of ischemia and reperfusion that tolerated a more prolonged episode of ischemia better than myocardium not previously exposed to ischemia. Protective effect of myocardial ischemic PC was demonstrated in several animal species, resulting in the strongest endogenous form of protection against myocardial injury, jeopardized myocardium, infarct size, and arrhythmias other than early reperfusion. New onset angina before acute myocardial infarction, episodes of myocardial ischemia during coronary angioplasty or bypass surgery, and the "warm-up" phenomenon may represent clinical counterparts of the PC phenomenon in humans. Here, we have attempted to summarize pharmacological modulation, preclinical studies, and new clinical features of ischemic PC. To date, the pathophysiological basis of the "chemical PC" is still not well established, and "putting PC in a bottle" for clinical applications still remains a new pharmacological venture.
KW - Adenosine
KW - Ischemic preconditioning
KW - K channels
KW - Myocardial ischemia
KW - Oxygen radicals
KW - Pharmacology
UR - http://www.scopus.com/inward/record.url?scp=0034451642&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034451642&partnerID=8YFLogxK
U2 - 10.1016/S0163-7258(00)00093-0
DO - 10.1016/S0163-7258(00)00093-0
M3 - Article
C2 - 11337029
AN - SCOPUS:0034451642
VL - 88
SP - 311
EP - 331
JO - Pharmacology and Therapeutics, Part A: Chemotherapy, Toxicology and
JF - Pharmacology and Therapeutics, Part A: Chemotherapy, Toxicology and
SN - 0163-7258
IS - 3
ER -